Prosecutors Seeking Martha Indictment
Stewart, 61, has been the target of an investigation for having dumped her shares of the biotech company ImClone Systems Inc. in December 2001, one day before the Food and Drug Administration was to bypass approval of its colon cancer drug.
From the beginning, Stewart has denied any wrongdoing in her ImClone sale.
In a statement, Omnimedia said Stewart's lawyers informed the company that she is the target of a criminal investigation by the U.S. Attorney's Office for the Southern District of New York, and that a civil complaint by the Securities and Exchange Commission also is expected.
The statement didn't elaborate on the possible charges, said AP.
Omnimedia said its board of directors has been planning for a number of possible contingencies, is evaluating the current situation and will take action as appropriate.
AP's request for a comment from Stewart's attorney was not immediately answered.
The U.S. Attorney's Office had no immediate comment when reached Tuesday morning.
On Newsstands Now
- Kim's Delivery Room Drama!
- Katie: A Year After Split
- Princess Kate: Palace's Baby Plan Revealed
Pick up your copy on newsstands
Click here for instant access to the Digital Magazine